Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR3C2 |
| Upstream (Parents) |
|---|
| (<<) NR1I3 → NR3C2 |
| (<<) HOXD10 → NR3C2 |
| (<<) HMGA2 → NR3C2 |
| (<<) SOX4 → NR3C2 |
| (<<) MYT1 → NR3C2 |
| (<<) ARNT2 → NR3C2 |
| (<<) TP63 → NR3C2 |
| (<<) HOXD9 → NR3C2 |
| (<<) HOXA2 → NR3C2 |
| (<<) RORC → NR3C2 |
| (<<) NR1I2 → NR3C2 |
| (<<) ARID3A → NR3C2 |
| (<<) CEBPA → NR3C2 |
| (<<) ELF1 → NR3C2 |
| (<<) KLF11 → NR3C2 |
| Downstream (Children) |
|---|
| NR3C2 → NFE2 (>>) |
| NR3C2 → SIX1 (>>) |
| NR3C2 → NFIB (>>) |
| NR3C2 → SRY (>>) |
| NR3C2 → RBPJL (>>) |
| NR3C2 → AFF1 (>>) |
| NR3C2 → THRB (>>) |
| NR3C2 → HOXC4 (>>) |
| NR3C2 → HOXC13 (>>) |
